Why Exact Sciences Stock Skyrocketed Today
Shares of Exact Sciences (NASDAQ: EXAS) were skyrocketing 26.3% higher as of 3:20 p.m. EDT on Thursday. The big jump came after the company's CEO, Kevin Conroy, presented at the Cowen Liquid Biopsy Summit.
With Exact Sciences stock moving so much higher, you'd expect that Conroy's presentation was a doozy. Cowen analyst Doug Schenkel thought so. He said Exact Sciences "took a big step today to declare its intent to be a major liquid biopsy company." Liquid biopsies are blood tests that determine if a person has cancer by detecting fragments of DNA that have broken off from tumor cells.
Image source: Getty Images.
Source Fool.com
